Status:
COMPLETED
The Comparisons of One-stage Stone Removal in Mild and Moderate Cholangitis
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Cholangitis; Choledocholithiasis
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
In expert comment, performing the sphincterotomy for choledocholithiasis with acute cholangitis may increase bleeding and pancreatitis risks (from 2% to 10%). Therefore, investigators often perform bi...
Detailed Description
Investigators will enroll 204 naïve papilla with a body temperature ≥37 °C who was diagnosed with mild to moderate cholangitis associated with choledocholithiasis. The method of one-stage: performing ...
Eligibility Criteria
Inclusion
- naïve papilla with a body temperature ≥37 °C who was diagnosed with mild to moderate cholangitis associated with choledocholithiasis.
Exclusion
- procedural failure requiring an anatomy-modifying procedure, such as a Billroth II subtotal gastrectomy or R-en-Y gastrojejunostomy ;
- stenosis of the pyloric ring ;
- tumor-related obstruction;
- failure to locate the papilla ;
- active peptic ulcer bleeding ;
- intolerance due to inadequate sedation
- CBD sludge;
- non-naïve papilla in ERCP
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT03754491
Start Date
October 1 2018
End Date
March 31 2020
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 813